Transaction DateRecipientSharesTypePriceValue
1st October 2020David F Melcher3,320Exercise of derivative$0.00
10th September 2020Vincent A Forlenza4.289Grant/award etc.$286.39$1,228.33
1st September 2020Thomas J Spoerel59Payment by withholding$0.00
21st July 2020Catherine M Burzik1,983Grant/award etc.$0.00
21st July 2020Claire Pomeroy1,983Grant/award etc.$0.00
10th July 2020Vincent A Forlenza11,660Bona fide gift$0.00
9th July 2020Patrick Kaltenbach1,272Open or private sale$260.00$330,720.00
30th June 2020Vincent A Forlenza21,192Bona fide gift$0.00
10th June 2020Vincent A Forlenza4.422Grant/award etc.$277.27$1,226.09
8th June 2020Timothy M Ring820Exercise of derivative$61.62$50,524.30
Becton Dickinson & Co.
Becton Dickinson & Co. logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.

Ticker: BDX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 10795
Employees: 70093
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags